Laurion Capital Management’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | – | Sell |
-11,157
| Closed | -$91.7K | – | 459 |
|
2024
Q2 | $91.7K | Buy |
+11,157
| New | +$91.7K | ﹤0.01% | 392 |
|
2023
Q2 | – | Sell |
-984,961
| Closed | -$22.2M | – | 465 |
|
2023
Q1 | $22.2M | Buy |
984,961
+150,000
| +18% | +$3.37M | 0.15% | 23 |
|
2022
Q4 | $17.6M | Hold |
834,961
| – | – | 0.08% | 37 |
|
2022
Q3 | $20.6M | Hold |
834,961
| – | – | 0.12% | 38 |
|
2022
Q2 | $20.2M | Sell |
834,961
-33,817
| -4% | -$819K | 0.31% | 21 |
|
2022
Q1 | $22.4M | Sell |
868,778
-40,173
| -4% | -$1.04M | 0.27% | 28 |
|
2021
Q4 | $28.2M | Buy |
908,951
+150,000
| +20% | +$4.66M | 0.29% | 38 |
|
2021
Q3 | $18.4M | Buy |
758,951
+191,768
| +34% | +$4.65M | 0.08% | 69 |
|
2021
Q2 | $8.28M | Buy |
567,183
+304,170
| +116% | +$4.44M | 0.05% | 82 |
|
2021
Q1 | $6.57M | Buy |
+263,013
| New | +$6.57M | 0.04% | 141 |
|
2015
Q3 | – | Sell |
-227,898
| Closed | -$7.56M | – | 642 |
|
2015
Q2 | $7.56M | Sell |
227,898
-192,779
| -46% | -$6.39M | 0.07% | 58 |
|
2015
Q1 | $10.1M | Buy |
420,677
+233,498
| +125% | +$5.59M | 0.2% | 26 |
|
2014
Q4 | $2.29M | Buy |
+187,179
| New | +$2.29M | 0.05% | 56 |
|